Malignancy may adversely influence the quality and behaviour of oocytes.
Pal L, Leykin L, Schifren J, Isaacson K, Chang Y, Nikruil N, Chen Z, Toth T. Malignancy may adversely influence the quality and behaviour of oocytes. Human Reproduction 1998, 13: 1837-1840. PMID: 9740435, DOI: 10.1093/humrep/13.7.1837.Peer-Reviewed Original ResearchConceptsMalignant diseaseMalignant disordersAge-matched patientsCell of originTubal infertilityIVF cyclesOvarian stimulationDefinitive treatmentCase seriesCertain malignanciesNeoplastic processPatientsComparable total numberMature oocytesMalignancyFertilization rateDiseasePotential fertilityApparent adverse influenceOocytesPoor qualityDisordersTotal numberAdverse influenceInfertilityImpact of Varying Stages of Endometriosis on the Outcome of In Vitro Fertilization–Embryo Transfer
Pal L, Shifren J, Isaacson K, Chang Y, Leykin L, Toth T. Impact of Varying Stages of Endometriosis on the Outcome of In Vitro Fertilization–Embryo Transfer. Journal Of Assisted Reproduction And Genetics 1998, 15: 27-31. PMID: 9493063, PMCID: PMC3468198, DOI: 10.1023/a:1022574221115.Peer-Reviewed Original ResearchConceptsSeverity of endometriosisMale factor infertilityIVF cyclesIVF-ETGroup BGroup AIVF-embryo transfer cyclesVitro Fertilization-Embryo TransferAmerican Fertility Society classificationGonadotropin-releasing hormone agonistAcademic IVF programDay 3 follicleHuman menopausal gonadotropinCycles of IVFFertilization-embryo transferIU/LCombination of FSHOocytes of patientsSeverity of diseaseQuality of oocytesImpact of severityMenopausal gonadotropinOvarian hyperstimulationAdvanced diseaseClinical pregnancy